On Friday, Zomedica Corp (AMEX: ZOM) was 1.00% up from the session before settling in for the closing price of $0.12. A 52-week range for ZOM has been $0.12 – $0.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 78.21%. With a float of $962.51 million, this company’s outstanding shares have now reached $979.95 million.
The extent of productivity of a business whose workforce counts for 144 workers is very important to gauge. In terms of profitability, gross margin is 53.94%, operating margin of -140.99%, and the pretax margin is -221.49%.
Zomedica Corp (ZOM) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zomedica Corp stocks. The insider ownership of Zomedica Corp is 1.78%, while institutional ownership is 8.60%. The most recent insider transaction that took place on Sep 05 ’24, was worth 12,500. In this transaction CEO of this company bought 100,000 shares at a rate of $0.12, taking the stock ownership to the 400,000 shares. Before that another transaction happened on Aug 28 ’24, when Company’s Director bought 100,000 for $0.13, making the entire transaction worth $12,900. This insider now owns 2,325,000 shares in total.
Zomedica Corp (ZOM) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2023, it has been observed that the corporation posted -0.01 earnings per share (EPS) during the time that was less than consensus figure (set at 0) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Zomedica Corp (AMEX: ZOM) Trading Performance Indicators
You can see what Zomedica Corp (ZOM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.06
Technical Analysis of Zomedica Corp (ZOM)
The latest stats from [Zomedica Corp, ZOM] show that its last 5-days average volume of 4.56 million was inferior to 4.56 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 5.72%. Additionally, its Average True Range was 0.00.
During the past 100 days, Zomedica Corp’s (ZOM) raw stochastic average was set at 2.70%, which indicates a significant decrease from 9.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.45% in the past 14 days, which was lower than the 39.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1295, while its 200-day Moving Average is $0.1407. Now, the first resistance to watch is $0.1219. This is followed by the second major resistance level at $0.1228. The third major resistance level sits at $0.1239. If the price goes on to break the first support level at $0.1199, it is likely to go to the next support level at $0.1188. The third support level lies at $0.1179 if the price breaches the second support level.
Zomedica Corp (AMEX: ZOM) Key Stats
There are 979,950K outstanding shares of the company, which has a market capitalization of 118.48 million. As of now, sales total 25,190 K while income totals -34,530 K. Its latest quarter income was 6,130 K while its last quarter net income were -23,930 K.
